Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study-Reference-Cited by-同舟云学术

Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study

Published:2019-07 Issue:3 Volume:9 Page:1-3
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Richter Manuel J.¹,Wan Jun²,Ghofrani Hossein A.¹³⁴,Seeger Werner¹,Gall Henning¹^ORCID,Rieth Andreas⁵,Tello Khodr¹

Affiliation:

1. Department of Internal MedicineJustus‐Liebig‐University GiessenUniversities of Giessen and Marburg Lung Center (UGMLC)Member of the German Center for Lung Research (DZL)GiessenGermany

2. Department of Pulmonary and Critical Care MedicineNational Pulmonary Embolism & Pulmonary Vascular Diseases Research GroupNational Clinical Research Center for Respiratory DiseasesChina–Japan Friendship HospitalBeijingChina

3. Department of PneumologyKerckhoff HeartRheuma and Thoracic CenterBad NauheimGermany

4. Department of MedicineImperial College LondonLondonUK

5. Department of CardiologyKerckhoff HeartRheuma and Thoracic CenterBad NauheimGermany

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045894019875342

Reference12 articles.

1. Inhaled iloprost for the control of pulmonary hypertension;Krug S;Vasc Health Risk Manag,2009

2. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT);Galie N;Eur Respir J,2015

3. Inhaled iloprost for severe pulmonary hypertension;Olschewski H;N Engl J Med,2002

4. The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension;Gessler T;Pulm Circ,2017

5. Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial;Richter MJ;Pulm Circ,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostacyclin analogues decrease platelet aggregation but have no effect on thrombin generation, fibrin clot structure, and fibrinolysis in pulmonary arterial hypertension: PAPAYA coagulation;Platelets;2022-03-14

2. Modification Tadalafil and Macitentan tablets to aerosol;Frontiers in Bioscience-Landmark;2022-01-13

3. Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP);Journal of Medical Internet Research;2021-10-08

4. Prostacyclin Analogues Inhibit Platelet Reactivity, Extracellular Vesicle Release and Thrombus Formation in Patients with Pulmonary Arterial Hypertension;Journal of Clinical Medicine;2021-03-02

5. Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP) (Preprint);2020-11-04